- Report
- September 2021
- 40 Pages
China
From €2366EUR$2,600USD£2,029GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Pentasa is a brand of mesalamine, an anti-inflammatory drug used to treat ulcerative colitis, Crohn's disease, and other gastrointestinal disorders. It is a member of the aminosalicylate class of drugs, which are used to reduce inflammation in the digestive tract. Pentasa is available in both oral and rectal forms, and is often prescribed in combination with other medications. It is generally well-tolerated, with few side effects.
Pentasa is one of the leading medications used to treat gastrointestinal disorders, and is widely prescribed by doctors. It is available in many countries around the world, and is often covered by insurance plans.
The market for gastrointestinal drugs is highly competitive, with many companies offering similar products. Some of the major players in the market include AbbVie, AstraZeneca, Pfizer, Merck, and Takeda. Show Less Read more